Literature DB >> 22042537

Inflammation regulates microRNA expression in cooperation with p53 and nitric oxide.

Ewy Mathé1, Giang H Nguyen, Naotake Funamizu, Peijun He, Matthew Moake, Carlo M Croce, S Perwez Hussain.   

Abstract

microRNA (miRNA) are small non-coding RNA targeting mRNAs leading to their instability and diminished translation. Altered expression of miRNA is associated with cancer. Inflammation and nitric oxide modulates the development of lymphomas in p53 knockout mice and there exists a negative feedback loop between p53 and NOS2. Using a genetic strategy, we tested the hypothesis that inflammation-induced oxidative and nitrosative stress modulates miRNA expression in mouse model deficient in either p53 or NOS2. Mice treated with Corynebacterium parvum (C. parvum), to induce inflammation, clearly separated from controls by their miRNA profiles in wild-type, p53- and NOS2-knockout genetic backgrounds. C. parvum-induced inflammation significantly (p < 0.005) increased miR-21, miR-29b and miR-34a/b/c and decreased (p < 0.005) mir-29c and mir-181a/c expression in the spleen of C57BL mice. However, p53-knockout C57BL mice did not show a significant increase in the mir-34b/c or a decrease in mir-29c expression following C. parvum-induced inflammation. Expression of mir-21, mir-29b and mir-181a was independent of p53-status. NOS2-knockout C57BL mice showed a significant increase in miR-21 and miR-34a/b/c and decrease in miR-181a similar to the wild-type (WT) mice following C. parvum-induced inflammation. However, in contrast to the WT mice, miR-29b/c expression was not affected following C. parvum-induced inflammation in NOS2 knockout mice. N-acetyl cysteine, an anti-oxidant, reduced the expression of miR-21 and miR-29b in C. parvum-treated WT mice (p < 0.005) as compared with control C. parvum-treated mice. These data are consistent with the hypothesis that inflammation modulates miRNA expression in vivo and the alteration in specific miRNA under an inflammatory microenvironment, can be influenced by p53 (miR-34b/c) and NO(•) (29b/c).
Copyright © 2011 UICC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22042537      PMCID: PMC3299894          DOI: 10.1002/ijc.26403

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  26 in total

Review 1.  p53 enters the microRNA world.

Authors:  Heiko Hermeking
Journal:  Cancer Cell       Date:  2007-11       Impact factor: 31.743

2.  Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer.

Authors:  Dennis Löffler; Katja Brocke-Heidrich; Gabriele Pfeifer; Claudia Stocsits; Jörg Hackermüller; Antje K Kretzschmar; Renate Burger; Martin Gramatzki; Conny Blumert; Kay Bauer; Helena Cvijic; A Kerstin Ullmann; Peter F Stadler; Friedemann Horn
Journal:  Blood       Date:  2007-05-11       Impact factor: 22.113

Review 3.  Inflammation and cancer: an ancient link with novel potentials.

Authors:  S Perwez Hussain; Curtis C Harris
Journal:  Int J Cancer       Date:  2007-12-01       Impact factor: 7.396

4.  MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B.

Authors:  Muller Fabbri; Ramiro Garzon; Amelia Cimmino; Zhongfa Liu; Nicola Zanesi; Elisa Callegari; Shujun Liu; Hansjuerg Alder; Stefan Costinean; Cecilia Fernandez-Cymering; Stefano Volinia; Gulnur Guler; Carl D Morrison; Kenneth K Chan; Guido Marcucci; George A Calin; Kay Huebner; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-21       Impact factor: 11.205

Review 5.  Tumor stroma and regulation of cancer development.

Authors:  Thea D Tlsty; Lisa M Coussens
Journal:  Annu Rev Pathol       Date:  2006       Impact factor: 23.472

6.  A microRNA component of the p53 tumour suppressor network.

Authors:  Lin He; Xingyue He; Lee P Lim; Elisa de Stanchina; Zhenyu Xuan; Yu Liang; Wen Xue; Lars Zender; Jill Magnus; Dana Ridzon; Aimee L Jackson; Peter S Linsley; Caifu Chen; Scott W Lowe; Michele A Cleary; Gregory J Hannon
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

7.  MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha.

Authors:  Feng Wu; Michelle Zikusoka; Anil Trindade; Themistocles Dassopoulos; Mary L Harris; Theodore M Bayless; Steven R Brant; Shukti Chakravarti; John H Kwon
Journal:  Gastroenterology       Date:  2008-08-03       Impact factor: 22.682

8.  Suppression of non-small cell lung tumor development by the let-7 microRNA family.

Authors:  Madhu S Kumar; Stefan J Erkeland; Ryan E Pester; Cindy Y Chen; Margaret S Ebert; Phillip A Sharp; Tyler Jacks
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-28       Impact factor: 11.205

9.  Involvement of MicroRNAs in hydrogen peroxide-mediated gene regulation and cellular injury response in vascular smooth muscle cells.

Authors:  Ying Lin; Xiaojun Liu; Yunhui Cheng; Jian Yang; Yuqing Huo; Chunxiang Zhang
Journal:  J Biol Chem       Date:  2009-01-21       Impact factor: 5.157

10.  Nitric oxide is a key component in inflammation-accelerated tumorigenesis.

Authors:  S Perwez Hussain; Peijun He; Jeffery Subleski; Lorne J Hofseth; Glenwood E Trivers; Leah Mechanic; Anne B Hofseth; Mark Bernard; Jonathan Schwank; Giang Nguyen; Ewy Mathe; Draginja Djurickovic; Diana Haines; Jonathan Weiss; Timothy Back; Eilene Gruys; Victor E Laubach; Robert H Wiltrout; Curtis C Harris
Journal:  Cancer Res       Date:  2008-09-01       Impact factor: 12.701

View more
  25 in total

1.  NOS2 enhances KRAS-induced lung carcinogenesis, inflammation and microRNA-21 expression.

Authors:  Hirokazu Okayama; Motonobu Saito; Naohide Oue; Jonathan M Weiss; Jimmy Stauffer; Seiichi Takenoshita; Robert H Wiltrout; S Perwez Hussain; Curtis C Harris
Journal:  Int J Cancer       Date:  2012-06-13       Impact factor: 7.396

Review 2.  Targeting CSCs in tumor microenvironment: the potential role of ROS-associated miRNAs in tumor aggressiveness.

Authors:  Bin Bao; Asfar S Azmi; Yiwei Li; Aamir Ahmad; Shadan Ali; Sanjeev Banerjee; Dejuan Kong; Fazlul H Sarkar
Journal:  Curr Stem Cell Res Ther       Date:  2014-01       Impact factor: 3.828

3.  Regulation of the extrinsic apoptotic pathway by microRNA-21 in alcoholic liver injury.

Authors:  Heather Francis; Kelly McDaniel; Yuyan Han; Xiuping Liu; Lindsey Kennedy; Fuquan Yang; Jennifer McCarra; Tianhao Zhou; Shannon Glaser; Julie Venter; Li Huang; Phillip Levine; Jia-Ming Lai; Chang-Gong Liu; Gianfranco Alpini; Fanyin Meng
Journal:  J Biol Chem       Date:  2014-08-12       Impact factor: 5.157

4.  MicroRNA-29a/b/c targets iNOS and is involved in protective remote ischemic preconditioning in an ischemia-reperfusion rat model of non-alcoholic fatty liver disease.

Authors:  Yun-Fei Duan; Dong-Lin Sun; Jing Chen; Feng Zhu; Yong An
Journal:  Oncol Lett       Date:  2017-01-18       Impact factor: 2.967

5.  NOD2-nitric oxide-responsive microRNA-146a activates Sonic hedgehog signaling to orchestrate inflammatory responses in murine model of inflammatory bowel disease.

Authors:  Devram Sampat Ghorpade; Akhuri Yash Sinha; Sahana Holla; Vikas Singh; Kithiganahalli Narayanaswamy Balaji
Journal:  J Biol Chem       Date:  2013-10-03       Impact factor: 5.157

Review 6.  NO and Pancreatic Cancer: A Complex Interaction with Therapeutic Potential.

Authors:  Jian Wang; S Perwez Hussain
Journal:  Antioxid Redox Signal       Date:  2016-09-22       Impact factor: 8.401

7.  Macrophages, nitric oxide and microRNAs are associated with DNA damage response pathway and senescence in inflammatory bowel disease.

Authors:  Jane J Sohn; Aaron J Schetter; Harris G Yfantis; Lisa A Ridnour; Izumi Horikawa; Mohammed A Khan; Ana I Robles; S Perwez Hussain; Akiteru Goto; Elise D Bowman; Lorne J Hofseth; Jirina Bartkova; Jiri Bartek; Gerald N Wogan; David A Wink; Curtis C Harris
Journal:  PLoS One       Date:  2012-09-06       Impact factor: 3.240

Review 8.  Role of Nitric Oxide in Gene Expression Regulation during Cancer: Epigenetic Modifications and Non-Coding RNAs.

Authors:  Patricia de la Cruz-Ojeda; Rocío Flores-Campos; Sandra Dios-Barbeito; Elena Navarro-Villarán; Jordi Muntané
Journal:  Int J Mol Sci       Date:  2021-06-10       Impact factor: 5.923

9.  Bladder cancer: a simple model becomes complex.

Authors:  Giovanni Battista Di Pierro; Caterina Gulia; Cristiano Cristini; Giorgio Fraietta; Lorenzo Marini; Pietro Grande; Vincenzo Gentile; Roberto Piergentili
Journal:  Curr Genomics       Date:  2012-08       Impact factor: 2.236

10.  Associations of pri-miR-34b/c and pre-miR-196a2 polymorphisms and their multiplicative interactions with hepatitis B virus mutations with hepatocellular carcinoma risk.

Authors:  Yifang Han; Rui Pu; Xue Han; Jun Zhao; Yuwei Zhang; Qi Zhang; Jianhua Yin; Jiaxin Xie; Qiuxia Shen; Yang Deng; Yibo Ding; Weiping Li; Juhong Li; Hongwei Zhang; Guangwen Cao
Journal:  PLoS One       Date:  2013-03-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.